IPO
-
-
-
-
-
-
-
Vasta Announces Transition Period of Its Chief Financial Officer
-
-
-
-
-
-
-
Vasta Announces Third Quarter 2021 Results
-
-
-
-
-
-
-
Vasta Announces Fourth Quarter 2020 Results
-
-
-
-
-
-
-
Vasta Platform Limited Reports Second Quarter and First Half 2020 Financial Results
-
-
-
-
-
-
-
Chardan Capital Starts VistaGen Therapeutics (VSTA) at Buy; Positive on AV-101 as Antidepressant Sans Ketamine Side Effects
99,413 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All